RIME Therapeutics
PrivateLast Round
Seed
Apr 30, 2026
Total Funding Raised
$100,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
RIME Therapeutics is a biotechnology company that provides a peptide-based drug discovery platform to identify protein-protein interaction targets and accelerate small molecule development for inflammation and immunology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RIME Therapeutics Comparables
Compare RIME Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oryn Therapeutics | 76% | |
| Azcuris | 65% | |
| AbbVie | 63% |
RIME Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 30, 2026 | ||||
| Accelerator | Jul 1, 2025 |
Key People
Founding team and executive leadership
RIME Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Amplitude Ventures | Seed |
| Consortium Québécois sur la découverte du médicament | Accelerator, Seed |
| Merck Digital Sciences Studio | Accelerator |
| Merck Capital Ventures | Accelerator |
| Centech | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 30, 2026
Seed round led by Amplitude Ventures.
- Jul 1, 2025
$100K round led by Merck Digital Sciences Studio.
RIME Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about RIME Therapeutics's valuation, stock price, and market status.
Is RIME Therapeutics a public or private company?
RIME Therapeutics is a private company.
What is the current stock price of RIME Therapeutics?
RIME Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is RIME Therapeutics worth (valuation)?
Valuation information for RIME Therapeutics is not publicly available.
Can I buy RIME Therapeutics stock?
RIME Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was RIME Therapeutics's last funding round?
RIME Therapeutics's most recent funding round was Seed on April 30, 2026.
Who are the main investors in RIME Therapeutics?
Key investors in RIME Therapeutics include Amplitude Ventures, Merck Digital Sciences Studio.
Will RIME Therapeutics IPO soon?
No public IPO plans have been announced for RIME Therapeutics.
How can I track RIME Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RIME Therapeutics's secondary market activity and sign up for updates.